Market Cap 28.96B
Revenue (ttm) 15.46B
Net Income (ttm) 1.03B
EPS (ttm) N/A
PE Ratio 14.20
Forward PE 15.30
Profit Margin 6.66%
Debt to Equity Ratio 0.66
Volume 20,454,900
Avg Vol 31,435,596
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 35%
Beta 0.72
Analysts Sell
Price Target $20.36

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment...

Industry: Household & Personal Products
Sector: Consumer Defensive
Address:
1 Kenvue Way, Summit, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 4:50 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $KVUE Current Share Price: $15.00 Contracts: $KVUE January 15, 2027 $15 Calls Scale in: $2.66- $3.25 Scale out: $4.13-$5.31 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Finesttrade
Finesttrade Oct. 25 at 3:47 PM
$KVUE One of my favorites. Holding strong here. Waiting for the wind to blow in my favor.
0 · Reply
DRockTrading
DRockTrading Oct. 25 at 6:58 AM
$KVUE Very bullish on this one just need patience, even republican congress members are buying this stock now
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 25 at 3:59 AM
Starboard's Jeff Smith says the entire recent drop in Kenvue price is due to the Tylenol-Autism link accusation. $FLR $KVUE $SPY https://www.youtube.com/watch?v=FHeIGZNcFWg
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 25 at 2:12 AM
Morningstar's list of 12 undervalued consumer defensive stocks that look attractive today. If you're going to pick from this list, pick ones that have not run and have a wide moat. $CPB $KVUE $STZ $SPY https://www.morningstar.com/stocks/best-consumer-defensive-stocks-buy
3 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 24 at 10:59 PM
$KVUE - Kenvue doesn't look bad here. Seems to be consolidating at the bottom, waiting for earnings. I still see price target of 18-19. Whereas, Johnson&Johnson seems a little extended and could pullback to 180 area. $SPY $JNJ
1 · Reply
SennaFan
SennaFan Oct. 24 at 8:51 PM
$KVUE just hope this will not turn out to be like $MLSS which I had to sell at a loss a while back. At the moment, they both appear to share the same trading patterns.
1 · Reply
RicNorway
RicNorway Oct. 24 at 6:23 PM
$KVUE these are going for .50 right now.
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 6:11 PM
Enter: $KVUE NOV 14 2025 $16 CALLS Buy in Price: $1.00 - $1.00 Take Profit: $1.76 Stop Bleeding: $0.88 ROI Potential: 76% https://moneygroup.us/
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 24 at 4:14 PM
$KVUE - With the amount of open interest for the Nov OpEx, Kenvue price will probably push up to at least $17 by then.
0 · Reply
Latest News on KVUE
Kenvue: A Rock Solid 5% Yield

Oct 15, 2025, 8:45 AM EDT - 10 days ago

Kenvue: A Rock Solid 5% Yield


Buy 2 Ideal Dividend Kings Of 25 'Safer' In October's 56

Oct 10, 2025, 12:51 AM EDT - 15 days ago

Buy 2 Ideal Dividend Kings Of 25 'Safer' In October's 56

UBSI


51 September S&P Hi-Yield Aristocrats: 5 To Buy

Sep 26, 2025, 7:08 AM EDT - 4 weeks ago

51 September S&P Hi-Yield Aristocrats: 5 To Buy

AMCR AVA BEN EIX FLO HRL KO


Kenvue: This Too Shall Pass

Sep 24, 2025, 2:36 PM EDT - 4 weeks ago

Kenvue: This Too Shall Pass


Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism

Sep 23, 2025, 3:20 PM EDT - 4 weeks ago

Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism


Tylenol: Kenvue's Sobering Reality

Sep 23, 2025, 10:43 AM EDT - 4 weeks ago

Tylenol: Kenvue's Sobering Reality


Trump Sounds The Alarm On Tylenol

Sep 23, 2025, 7:30 AM EDT - 4 weeks ago

Trump Sounds The Alarm On Tylenol


Wall Street Breakfast Podcast: Kenvue In Focus

Sep 23, 2025, 6:33 AM EDT - 4 weeks ago

Wall Street Breakfast Podcast: Kenvue In Focus

BA META


Tylenol-maker Kenvue shares bounce, Trump claims face pushback

Sep 23, 2025, 4:01 AM EDT - 4 weeks ago

Tylenol-maker Kenvue shares bounce, Trump claims face pushback


Final Trade: AAPL, C, PFE, KVUE

Sep 22, 2025, 6:34 PM EDT - 4 weeks ago

Final Trade: AAPL, C, PFE, KVUE

AAPL C PFE


Top Stock Movers Now: Nvidia, Apple, Kenvue, and More

Sep 22, 2025, 2:20 PM EDT - 4 weeks ago

Top Stock Movers Now: Nvidia, Apple, Kenvue, and More

AAPL NVDA


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 4:50 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $KVUE Current Share Price: $15.00 Contracts: $KVUE January 15, 2027 $15 Calls Scale in: $2.66- $3.25 Scale out: $4.13-$5.31 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Finesttrade
Finesttrade Oct. 25 at 3:47 PM
$KVUE One of my favorites. Holding strong here. Waiting for the wind to blow in my favor.
0 · Reply
DRockTrading
DRockTrading Oct. 25 at 6:58 AM
$KVUE Very bullish on this one just need patience, even republican congress members are buying this stock now
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 25 at 3:59 AM
Starboard's Jeff Smith says the entire recent drop in Kenvue price is due to the Tylenol-Autism link accusation. $FLR $KVUE $SPY https://www.youtube.com/watch?v=FHeIGZNcFWg
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 25 at 2:12 AM
Morningstar's list of 12 undervalued consumer defensive stocks that look attractive today. If you're going to pick from this list, pick ones that have not run and have a wide moat. $CPB $KVUE $STZ $SPY https://www.morningstar.com/stocks/best-consumer-defensive-stocks-buy
3 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 24 at 10:59 PM
$KVUE - Kenvue doesn't look bad here. Seems to be consolidating at the bottom, waiting for earnings. I still see price target of 18-19. Whereas, Johnson&Johnson seems a little extended and could pullback to 180 area. $SPY $JNJ
1 · Reply
SennaFan
SennaFan Oct. 24 at 8:51 PM
$KVUE just hope this will not turn out to be like $MLSS which I had to sell at a loss a while back. At the moment, they both appear to share the same trading patterns.
1 · Reply
RicNorway
RicNorway Oct. 24 at 6:23 PM
$KVUE these are going for .50 right now.
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 6:11 PM
Enter: $KVUE NOV 14 2025 $16 CALLS Buy in Price: $1.00 - $1.00 Take Profit: $1.76 Stop Bleeding: $0.88 ROI Potential: 76% https://moneygroup.us/
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 24 at 4:14 PM
$KVUE - With the amount of open interest for the Nov OpEx, Kenvue price will probably push up to at least $17 by then.
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 24 at 3:04 PM
$KVUE seems to be consolidating, probably for a move up. But, who really knows.
0 · Reply
TheIndustrials
TheIndustrials Oct. 24 at 2:27 PM
$KVUE Never participates in any of the rallies.
1 · Reply
TheGreenBar
TheGreenBar Oct. 24 at 2:19 PM
$KVUE constant suppression will end soon. this is not a penny stock…
0 · Reply
NeverCapProfit
NeverCapProfit Oct. 24 at 2:00 PM
$KVUE is too flat
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Oct. 24 at 1:48 PM
$KVUE $24 If it takes 3 years to get there, so be it. Ill be up on dividends alone.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 2:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $KVUE Current Share Price: $15.09 Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $1.81- $2.22 Scale out: $2.82-$3.63 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
SennaFan
SennaFan Oct. 24 at 12:46 AM
$KVUE I took another Tylenol today. For that reason, I'm not selling.
0 · Reply
DougieFreshPicks
DougieFreshPicks Oct. 23 at 11:52 PM
Night Note from last night 💸 $AREB up over 50% ✅ $KVUE setting up ❌ $LDI nice runner today ✅ Gave out more winning plays as well thats what your missing out on in the Discord 💯 https://linktr.ee/dougiefreshpicksdiscord
0 · Reply
StrayTrader
StrayTrader Oct. 23 at 11:22 PM
$KVUE this stock is dead in the water after the double hits of false and scientifically unfounded Tylenol/autism claims, plus the news of a UK class action lawsuit for damages arising from cancer allegedly caused by the use of talc-based baby powder. A rational assessment of the *actual* potential liability from these two categories of claims shows that the $15B lopped off the market cap is wildly excessive. The overreaction is driven by fear, headlines, algos, and of course Trump pounding the table that Tylenol causes autism. He probably thinks he should now get the Nobel prize in medicine for preventing autism. It is, of course, nonsense. So, buy when others are fearful; at $15/share you’re getting some of the best consumer brands at a 30-40% discount to fair value.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 4:03 PM
Enter: $KVUE NOV 14 2025 $16 CALLS Buy in Price: $1.02 - $1.07 Take Profit: $1.91 Stop Bleeding: $0.90 ROI Potential: 87% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Suite510
Suite510 Oct. 23 at 11:31 AM
$JNJ $KVUE Scum bags won’t even pay their fake Bankruptcy lawyers 😂 Brown Rudnick Fights J&J Unit Over $4 Million Bankruptcy Tab
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 23 at 5:03 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $KVUE Current Share Price: $15.19 Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $1.86- $2.28 Scale out: $2.90-$3.73 Can Easily Capture: 60% ROI Blended DTE: 450 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply